Neuron23

Neuron23

Biotechnology Research

South San Francisco, California 4,150 followers

We are a biotech company focused on developing precision medicines for neurological and immunological diseases.

About us

Neuron23™ Inc. is a leading clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The Company’s focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Founded in 2018, Neuron23 has assembled a world-class team of experts and entrepreneurs located in South San Francisco, CA.

Website
https://neuron23.com
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
South San Francisco, California
Type
Privately Held
Founded
2018
Specialties
biotech, precision medicine, immunological diseases, neurological diseases, neurodegenerative diseases, neuroinflammatory diseases, autoimmune diseases, inflammatory diseases, human genetics, data science, Parkinson's disease, Crohn's disease, Ulcerative colitis, psoriasis, IBD, and ankylosing spondylitis

Locations

  • Primary

    343 Oyster Point Blvd

    Suite 120

    South San Francisco, California 94080, US

    Get directions

Employees at Neuron23

Updates

Similar pages

Browse jobs

Funding